PDF) The Pitfalls of CA19-9 Routine Testing and Comparison of Two Automated Immunoassays in a Reference Oncology Center
Biomarkers in molecular medicine: cancer detection and diagnosis | BioTechniques
Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
CISN - The Promise of Tumor Markers
The promise and pitfalls of gene testing for cancer risk
CISN - The Promise of Tumor Markers
Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study | HTML
Tumor Marker - an overview | ScienceDirect Topics
Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer | npj Breast Cancer
Cell‐free tumour DNA testing for early detection of cancer – a potential future tool - Barbany - 2019 - Journal of Internal Medicine - Wiley Online Library
![PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e977c065bbeedc4ec3317993fa3477329dffa910/4-TableI-1.png "PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar")
PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar
A Bad Tumor Marker Test Is as Bad as a Bad Drug: The Case for More Consistent Regulation of Cancer Diagnostics | ASCO Connection
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer | SpringerLink
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know | HTML
State-of-the-Art Management of Germ Cell Tumors | American Society of Clinical Oncology Educational Book
Full article: Tumor markers in clinical practice: General principles and guidelines
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology
Tumor markers in cancer diagnosis and prognosis
What are cancer markers? - Quora
Tumor Marker - an overview | ScienceDirect Topics
The Basics - Tumour markers explained | GPonline
Tumor markers in cancer diagnosis and prognosis
What Breast Medical Oncologists Need From Pathologists: Overview, Tumor Size, Histologic Grade
